Heidi Harjunpää

2.9k total citations · 3 hit papers
20 papers, 2.1k citations indexed

About

Heidi Harjunpää is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Heidi Harjunpää has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Heidi Harjunpää's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Heidi Harjunpää is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Heidi Harjunpää collaborates with scholars based in Finland, Australia and Japan. Heidi Harjunpää's co-authors include Camille Guillerey, Susanna C. Fagerholm, Carla Guenther, Marc Llort Asens, Mark J. Smyth, Michele W.L. Teng, Stacey Allen, Kazuyoshi Takeda, Stephen J. Blake and Jake S. O’Donnell and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Heidi Harjunpää

19 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

2016 569 citations Jing Liu, Stephen J. Blake et al. Cancer Discovery profile →
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment

2019 511 citations Heidi Harjunpää, Marc Llort Asens et al. Frontiers in Immunology profile →
TIGIT as an emerging immune checkpoint

2019 389 citations Heidi Harjunpää, Camille Guillerey Clinical & Experimental Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi Harjunpää Finland	14	1.3k	934	458	393	195	20	2.1k
Sydney Gordon United States	8	1.4k 1.1×	1.7k 1.9×	740 1.6×	293 0.7×	185 0.9×	10	2.8k
Catherine Sabatos-Peyton United States	13	1.1k 0.9×	1.2k 1.3×	475 1.0×	233 0.6×	90 0.5×	23	2.1k
Colm R. Duffy United States	4	1.6k 1.3×	1.1k 1.2×	514 1.1×	394 1.0×	127 0.7×	11	2.3k
Yibei Zhu China	27	1.8k 1.4×	2.1k 2.2×	538 1.2×	362 0.9×	415 2.1×	55	3.1k
Christophe Borg France	22	652 0.5×	1.3k 1.3×	500 1.1×	168 0.4×	370 1.9×	48	2.3k
Jai Rautela Australia	19	1.0k 0.8×	1.3k 1.4×	648 1.4×	136 0.3×	86 0.4×	31	2.1k
Helena Escuin-Ordinas United States	13	1.4k 1.1×	1.0k 1.1×	644 1.4×	273 0.7×	80 0.4×	19	2.1k
Natalia Aptsiauri Spain	31	1.6k 1.3×	1.9k 2.1×	726 1.6×	200 0.5×	146 0.7×	55	2.9k
Ines Gütgemann Germany	25	1.1k 0.9×	1.2k 1.2×	1.3k 2.8×	332 0.8×	171 0.9×	60	3.0k
Todd T. Moore United States	12	1.8k 1.4×	1.4k 1.5×	686 1.5×	257 0.7×	319 1.6×	17	2.8k

Countries citing papers authored by Heidi Harjunpää

Since Specialization

Citations

This map shows the geographic impact of Heidi Harjunpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Harjunpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Harjunpää more than expected).

Fields of papers citing papers by Heidi Harjunpää

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Harjunpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Harjunpää. The network helps show where Heidi Harjunpää may publish in the future.

Co-authorship network of co-authors of Heidi Harjunpää

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Harjunpää. A scholar is included among the top collaborators of Heidi Harjunpää based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Harjunpää. Heidi Harjunpää is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imlimthan, Surachet, Heidi Harjunpää, Susanne Κ. Wiedmer, et al.. (2025). Aluminum-[18F]fluoride radiolabeling of triarylphosphines for cell labeling via the perfluoroaryl azide Staudinger ligation. EJNMMI Radiopharmacy and Chemistry. 10(1). 79–79.

Askari, S., et al.. (2025). Soft matter mechanics of immune cell aggregates. Journal of The Royal Society Interface. 22(228). 20250231–20250231. 1 indexed citations

Harjunpää, Heidi, Carla Guenther, Hock‐Kean Liew, et al.. (2024). β2-Integrins Regulate Microglial Responses and the Functional Outcome of Hemorrhagic Stroke In Vivo. The Journal of Immunology. 213(4). 519–525. 1 indexed citations

Harjunpää, Heidi, Manlio Fusciello, Sara Feola, et al.. (2024). Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses. OncoImmunology. 13(1). 2369373–2369373. 6 indexed citations

Guenther, Carla, Manlio Fusciello, Heidi Harjunpää, et al.. (2021). β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection. Cancer Immunology Research. 9(11). 1354–1369. 15 indexed citations

Guillerey, Camille, Kimberley Stannard, Jason Chen, et al.. (2020). Systemic administration of IL‐33 induces a population of circulating KLRG1^hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma. Immunology and Cell Biology. 99(1). 65–83. 8 indexed citations

Harjunpää, Heidi & Camille Guillerey. (2019). TIGIT as an emerging immune checkpoint. Clinical & Experimental Immunology. 200(2). 108–119. 389 indexed citations breakdown →

Guenther, Carla, Liisa M. Uotila, Marc Llort Asens, et al.. (2019). A β2-Integrin/MRTF-A/SRF Pathway Regulates Dendritic Cell Gene Expression, Adhesion, and Traction Force Generation. Frontiers in Immunology. 10. 1138–1138. 23 indexed citations

Harjunpää, Heidi, Marc Llort Asens, Carla Guenther, & Susanna C. Fagerholm. (2019). Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Frontiers in Immunology. 10. 1078–1078. 511 indexed citations breakdown →

10.

Yan, Juming, Stacey Allen, Dipti Vijayan, et al.. (2018). Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23. Cancer Immunology Research. 6(8). 978–987. 13 indexed citations

11.

Harjunpää, Heidi, Stephen J. Blake, Elizabeth Ahern, et al.. (2018). Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. OncoImmunology. 7(7). e1445949–e1445949. 37 indexed citations

12.

Ahern, Elizabeth, Heidi Harjunpää, Jake S. O’Donnell, et al.. (2018). RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer. OncoImmunology. 7(6). e1431088–e1431088. 69 indexed citations

13.

Guillerey, Camille, Heidi Harjunpää, Nadège Carrié, et al.. (2018). TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma. Blood. 132(16). 1689–1694. 222 indexed citations

14.

Niemi, Outi, Pia Laine, Patrik Koskinen, et al.. (2017). Genome sequence of the model plant pathogen Pectobacterium carotovorum SCC1. Standards in Genomic Sciences. 12(1). 87–87. 15 indexed citations

15.

Ahern, Elizabeth, Heidi Harjunpää, Deborah S. Barkauskas, et al.. (2017). Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice. Clinical Cancer Research. 23(19). 5789–5801. 68 indexed citations

16.

Liu, Jing, Stephen J. Blake, Heidi Harjunpää, et al.. (2016). Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer. Cancer Research. 76(18). 5288–5301. 76 indexed citations

17.

Liu, Jing, Stephen J. Blake, Michelle C.R. Yong, et al.. (2016). Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discovery. 6(12). 1382–1399. 569 indexed citations breakdown →

18.

Kaartinen, Tanja, Heidi Harjunpää, Jukka Partanen, & Minna Tiittanen. (2016). In Vitro Treg Expansion Favors the Full-Length Splicing Isoform of CTLA4. Immunotherapy. 8(5). 541–553. 1 indexed citations

19.

Koskinen, Jouko, Pia Laine, Outi Niemi, et al.. (2012). Genome Sequence of Pectobacterium sp. Strain SCC3193. Journal of Bacteriology. 194(21). 6004–6004. 15 indexed citations

20.

Harjunpää, Heidi, et al.. (2008). A Novel Plant Ferredoxin-Like Protein and the Regulator Hor Are Quorum-Sensing Targets in the Plant Pathogen Erwinia carotovora. Molecular Plant-Microbe Interactions. 21(7). 967–978. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact